Key takeaways
Entacapone (Comtan) and carbidopa / levodopa (Sinemet) are both medications used to treat Parkinson's disease (PD) by helping to relieve symptoms like shakiness and slowed movement. However, they belong to different medication classes. Entacapone is a catechol-O-methyltransferase (COMT) inhibitor, which works by blocking the COMT protein to prevent the breakdown of levodopa, allowing more levodopa to reach the brain. It is used alongside carbidopa / levodopa to enhance its effects. On the other hand, carbidopa / levodopa is a combination of a dopa decarboxylase inhibitor and dopamine replacement, which directly increases dopamine levels in the brain. Entacapone must be taken with each dose of carbidopa / levodopa. Carbidopa / levodopa can be taken in various forms, including immediate-release and extended-release tablets. Both medications are available in brand-name and generic forms. Common side effects of entacapone include involuntary movements and nausea, while carbidopa / levodopa can cause involuntary movements and nausea as well, but also dark-colored saliva, sweat, or urine. Both medications can cause sleepiness and should be used with caution if you have certain mental health conditions.
